Life is about so much more than
We invite those 18 to 55 years old who suffer from MS and have had at least 1 documented relapse in the last 24 months to see if they are eligible to participate in the Sunbeam Study. The purpose of this clinical research study is to determine the safety and effectiveness of an investigational oral drug for relapsing multiple sclerosis.
Each individual will be evaluated to determine his or her eligibility. Those who participate will receive the study drug, study-related medical examinations, and laboratory tests at no charge. Compensation for time and travel may also be available.